FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely neurology, and can be used to treat Alzheimer's disease. Use of a peptide of the general formula acetyl-D-LYS-Lys-ARG-ARG-amide for the treatment of Alzheimer's disease is proposed.
EFFECT: use of the invention makes it possible to achieve a stable nootropic effect on the scopolamine-induced model of Alzheimer's disease.
1 cl, 14 dwg, 3 ex, 8 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIDEPRESSANT AGENT | 2018 |
|
RU2741938C2 |
| PHARMACEUTICALLY ACCEPTABLE ACETYL-(D-LYS)-LYS-ARG-ARG-AMIDE PEPTIDE SALTS | 2021 |
|
RU2763136C1 |
| TETRAPEPTIDE AND PREPARATION, POSSESSING CEREBROPROTECTIVE AND ANTIAMNESTIC ACTIVITIES (VERSIONS) | 2013 |
|
RU2537560C2 |
| PHARMACEUTICAL COMPOSITION BASED ON HAEE PEPTIDE FOR TREATING NEURODEGENERATIVE DISEASES | 2019 |
|
RU2709539C1 |
| AGENT WITH ANTIAPOPTOTIC ACTIVITY | 2018 |
|
RU2685428C1 |
| DONECOPRID AS A NEUROPROTECTIVE AGENT IN THE TREATMENT OF NEURODEGERATIVE DISEASES | 2019 |
|
RU2800802C2 |
| COMPOSITION FOR TREATING OR PREVENTING NEURODEGENERATIVE DISORDERS | 2012 |
|
RU2699038C2 |
| PEPTIDE HAVING NEUROPROTECTIVE AND NOOTROPIC ACTIVITY AND PHARMACEUTICAL COMPOSITION BASED THEREON | 2014 |
|
RU2557003C2 |
| PEPTIDE COMPOUND, RESTORING FUNCTION OF RESPIRATORY BODIES AND INFLAMMABLE IMMUNOMODULATING ACTION | 2017 |
|
RU2667466C1 |
| THERAPEUTIC AGENT FOR ALZHEIMER'S DISEASE AND METHOD OF TREATING ALZHEIMER'S DISEASE | 2011 |
|
RU2536232C2 |
